Israel Englander Adaptive Biotechnologies Corp Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Millennium Management LLC holds 9,262,341 shares of ADPT stock, worth $44.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,262,341

Previous 835,761 1008.25%

Holding current value

$44.3 Million

Previous $2.68 Million 1150.15%

% of portfolio

0.02%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $19.7 Million - $33.4 Million	8,426,580 Added 1008.25%	9,262,341 $33.5 Million
Q1 2024 May 15, 2024	BUY	$2.88 - $4.8 $2.41 Million - $4.01 Million	835,761 New	835,761 $2.68 Million
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $248,076 - $351,876	-40,077 Reduced 31.3%	87,964 $590,000
Q1 2023 May 15, 2023	SELL	$7.8 - $10.11 $7.18 Million - $9.31 Million	-920,828 Reduced 87.79%	128,041 $1.13 Million
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $1.61 Million - $2.4 Million	257,045 Added 32.46%	1,048,869 $8.01 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $870,941 - $1.7 Million	133,991 Added 20.37%	791,824 $5.64 Million
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $435,251 - $1 Million	68,008 Added 11.53%	657,833 $5.32 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $4.44 Million - $12.7 Million	438,640 Added 290.13%	589,825 $8.19 Million
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $2.9 Million - $4.24 Million	115,078 Added 318.71%	151,185 $4.24 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $172,164 - $228,654	5,735 Added 18.88%	36,107 $1.23 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $323,617 - $447,861	-10,044 Reduced 24.85%	30,372 $1.24 Million
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $2.76 Million - $5.02 Million	-74,170 Reduced 64.73%	40,416 $1.63 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $2.54 Million - $3.69 Million	-56,432 Reduced 33.0%	114,586 $6.78 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $16.3 Million - $28.7 Million	-536,449 Reduced 75.83%	171,018 $5.28 Million
Q2 2019 Aug 15, 2019	BUY	$40.3 - $48.3 $26.4 Million - $31.7 Million	656,022 Added 1275.19%	707,467 $34.2 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $2.07 Million - $2.48 Million	51,445 New	51,445 $2.43 Million

Others Institutions Holding ADPT

# of Institutions

187

Shares Held

152M

Call Options Held

8.4K

Put Options Held

56K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $683M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account